Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for September 2009.

Pharmaceutical Technology
Volume 33, Issue 9, pp. 78

Milestones

Equity Firm Buys AAIPharma's Development Business

Water Street Healthcare Partners, a private-equity firm focused on the healthcare industry, acquired AAIPharma's (Wilmington, NC) pharmaceutical development division. Water Street has committed $75 million in equity financing to expand the business's capabilities. The new company is named AAIPharma Services.

The company, which will retain its headquarters in Wilmington, serves more than 300 large pharmaceutical and biotechnology companies throughout North America. Its team of 450 scientists and professionals specialize in services that encompass pharmaceutical drug development from discovery through commercialization. Its areas of expertise include analytical chemistry, formulation development, clinical packaging, oral drug delivery, and contract manufacturing.

Chemic Creates Consultant Consortium

Chemic Laboratories (Canton, MA) launched a new website ( http://www.chemiclabs.com/) to highlight its recently formed Chemic Consulting Consortium. The company chose members for their individual expertise, and the group is available to answer pharmaceutical and biotech sponsors' questions about pharmaceutical development. The consortium's goal is to guide clients through the challenges of product development and agency registration.

Schreiner Launches New Website

Schreiner MediPharm (Oberschleissheim, Germany), a global provider of specialty pharmaceutical labeling solutions, recently launched a completely renovated website ( http://www.schreiner-medipharm.com/). The site features a clear, modern design and layout; user-friendly, intuitive navigation; updated brand and product information; video sequences and animated images; and an improved press room that includes a section specifically for the US market.

Schreiner MediPharm develops and manufactures innovative specialty labels for the healthcare and pharmaceutical industries. The company has more than 50 years of experience and provides specialty labels and label-printing services to companies in more than 20 countries.

Spectrum Offers Fetal Bovine Serum

Spectrum Chemicals and Laboratory Products (Gardena, CA) launched a new line of premium-quality fetal bovine serum (FBS) products for various cell-culture applications. In partnership with an established biotechnology supplier, Spectrum offers FBS originating from abattoirs in the United States, Mexico, Canada, and Australia. Each FBS order includes a full biochemical and chemical profile, as well as certification of the country of origin. All of Spectrum's new serum products comply with current good manufacturing practice standards and with the regulations of the US Food and Drug Administration.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here